The Diarrhea drugs in development market research report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Diarrhea. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Diarrhea and features dormant and discontinued products.
GlobalData tracks 50 drugs in development for Diarrhea by 43 companies/universities/institutes. The top development phase for Diarrhea is preclinical with 27 drugs in that stage. The Diarrhea pipeline has 41 drugs in development by companies and nine by universities/ institutes. Some of the companies in the Diarrhea pipeline products market are: Cosmo Pharmaceuticals, Theriva Biologics and Scandinavian Biopharma Holding.
The key targets in the Diarrhea pipeline products market include Cystic Fibrosis Transmembrane Conductance Regulator, Bile Acid, and 5-Hydroxytryptamine Receptor 2B.
The key mechanisms of action in the Diarrhea pipeline product include Cystic Fibrosis Transmembrane Conductance Regulator Blocker with four drugs in Phase II. The Diarrhea pipeline products include four routes of administration with the top ROA being Oral and 15 key molecule types in the Diarrhea pipeline products market including Small Molecule, and Vaccine.
Diarrhea overview
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.
For a complete picture of Diarrhea’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
